These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36326412)

  • 1. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT.
    Çetin GP; Yılmaz İ; Türk M; Arslan B; Bahçecioğlu SN
    Turk J Med Sci; 2022 Aug; 52(4):1223-1234. PubMed ID: 36326412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
    Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
    Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
    Ridolo E; Pellicelli I; Kihlgren P; Nizi MC; Pucciarini F; Senna G; Incorvaia C
    Expert Opin Biol Ther; 2019 Sep; 19(9):919-925. PubMed ID: 31190572
    [No Abstract]   [Full Text] [Related]  

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush.
    Selcuk A; Baysan A; Yesillik S; Demirel F; Kartal O; Gulec M; Musabak U; Sener O
    Ann Med; 2022 Dec; 54(1):2321-2325. PubMed ID: 36111408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vespa velutina nigrithorax venom allergy: inhibition studies approach for the choice of specific immunotherapy.
    Grossi V; Severino M; Massolo A; Infantino M; Laureti F; Macchia D; Meucci E; Francescato E; Pantera B; Ebbli A; Fumagalli F; Lari B; Perri A; Liotti I; Ciotta G; Terenzi G; Valeva SV; Consolati M; Folgore T; Manfredi M
    Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):161-165. PubMed ID: 36515256
    [No Abstract]   [Full Text] [Related]  

  • 8. Field sting reactions in patients receiving Hymenoptera venom immunotherapy: real-life experience.
    Sözener ZÇ; Kendirlinan R; Çerçi P; Ayd N Ö; Mungan D; Bavbek S; Demirel Y; Mısırl Gil Z; Sin BA
    Asian Pac J Allergy Immunol; 2023 Sep; 41(3):186-192. PubMed ID: 35278056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of immunotherapy with aluminum hydroxide-adsorbed venom extract of Vespula spp. An open, retrospective study.
    Poli F; Longo G; Parmiani S
    Allergol Immunopathol (Madr); 2001; 29(5):191-6. PubMed ID: 11720652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM; Kagerer M; Cozzio A; Angelova-Fischer I; Guenova E; Ballmer-Weber B; Hoetzenecker W
    Int Arch Allergy Immunol; 2020; 181(10):783-789. PubMed ID: 32781451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous venom immunotherapy in children: Efficacy and safety.
    Gür Çetinkaya P; Esenboğa S; Uysal Soyer Ö; Tuncer A; Şekerel BE; Şahiner ÜM
    Ann Allergy Asthma Immunol; 2018 Apr; 120(4):424-428. PubMed ID: 29625665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose.
    Stretz E; Oppel EM; Räwer HC; Chatelain R; Mastnik S; Przybilla B; Ruëff F
    Clin Exp Allergy; 2017 Dec; 47(12):1631-1639. PubMed ID: 28802075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
    J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sting challenge: indications and execution].
    Ruëff F; Przybilla B
    Hautarzt; 2014 Sep; 65(9):796-801. PubMed ID: 25234628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.